Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Approach to the Patient With Nonalcoholic Fatty Liver Disease
Renata Belfort‐DeAguiar, Romina Lomonaco, Kenneth Cusi
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 2, pp. 483-495
Closed Access | Times Cited: 9

Showing 9 citing articles:

Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies
Idoia Genua, Kenneth Cusi
Diabetes Spectrum (2024) Vol. 37, Iss. 1, pp. 48-58
Open Access | Times Cited: 28
Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment
Norbert Stefan, Hannele Yki‐Järvinen, Brent A. Neuschwander‐Tetri
The Lancet Diabetes & Endocrinology (2024)
Open Access | Times Cited: 16
Diabetes and cirrhosis: Current concepts on diagnosis and management
Laurent Castéra, Kenneth Cusi
Hepatology (2023) Vol. 77, Iss. 6, pp. 2128-2146
Closed Access | Times Cited: 36
Making Sense of the Nonalcoholic Fatty Liver Disease Clinical Practice Guidelines: What Clinicians Need to Know
Kenneth Cusi, Jeff Budd, Eric L. Johnson, et al.
Diabetes Spectrum (2024) Vol. 37, Iss. 1, pp. 29-38
Open Access | Times Cited: 4
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors in Individuals with Suboptimal Cholesterol Levels
Federica Fogacci, Marina Giovannini, Antonio Di Micoli, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1587-1587
Open Access | Times Cited: 1
Serum remnant cholesterol is a potential predictor of liver stiffness in patients with nonalcoholic fatty liver disease
Ya Wang, Wanhan Song, Qianhua Yuan, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 59, Iss. 4, pp. 469-479
Closed Access | Times Cited: 4
Progress in the Study of the Hepatoprotective Effect of SGLT2i on NAFLD Patients with T2DM
Fan Yang, Xiaoping Tan
Journal of Biosciences and Medicines (2024) Vol. 12, Iss. 01, pp. 115-125
Open Access
Doença hepática gordurosa não alcoólica: uma revisão da fisiopatologia ao tratamento
Ivna Paola Arruda Câmara Virgolino, Camilla Rodrigues Paiva, Fatima Hassan Safieddine, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 3, pp. e69837-e69837
Open Access
FIB-4 index should guide the referral of patients with Metabolic Syndrome to Gastroenterology – the perspective of a Portuguese cohort
Marta Borges‐Canha, Rodrigo Liberal, Ana Rita Leite, et al.
Revista Portuguesa de Endocrinologia Diabetes e Metabolismo (2023), Iss. 1
Open Access
Page 1

Scroll to top